Article
Government expert panel recommends regular market approval for Covishield, Covaxin
Rating:
0.0
Views:
44
Likes:
1
Library:
1
🔴 Pharma companies Serum Institute of India (SII) and Bharat Biotech had submitted applications to the Drugs Controller General of India (DCGI) seeking regular market authorisation for their respective COVID-19 vaccines Covishield and Covaxin.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value